Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
Bacterial Infection, Sepsis, Infant, Newborn
About this trial
This is an interventional treatment trial for Bacterial Infection focused on measuring Neonatal sepsis, Neonatal pneumonia, Bacterial infections, Young infants, Neonate, Community, Developing country
Eligibility Criteria
Inclusion Criteria: Age 0-59 days presenting to Young Infant community study site Clinical diagnosis of possible serious bacterial infection by study physician according to specified clinical criteria Parents refuse to accept referral care and sign (or thumb imprint) document stating this. Parents consent to community centre-based intramuscular antibiotic injections Exclusion Criteria: Age over 59 days Presence of severe jaundice diagnosed clinically or by laboratory investigation (bilirubin > 12 g/dl in term and > 7 in pre-term baby). Presence of obvious meningitis (bulging fontanelle, observed seizures) Patient previously enrolled in antibiotic therapy trial Parents accept hospital referral Parents do not consent to any injectable therapy
Sites / Locations
- Aga Khan University community field sites